ANTIBODY PREVALENCE TO HEPATITIS-C AND PARENTERAL TRANSMITTED VIRUS DISEASES IN INTRAVENOUS-DRUG-USERS

被引：0
作者：
NEUWALD, C [1 ]
PONT, J [1 ]
TOMASITS, J [1 ]
BAUER, K [1 ]
机构：
[1] STADT WIEN,KAISER FRANZ JOSEF SPITALS,MED ABT 3,A-1100 VIENNA,AUSTRIA
来源：
ACTA MEDICA AUSTRIACA | 1992年 / 19卷 / 02期
关键词：
IV DRUG USERS; HEPATITIS-C; HEPATITIS-B; HIV; HTLV-I;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum samples of 151 intravenous drug users were tested for markers of hepatitis B, hepatitis C, HIV and HTLV-I infection to estimate the prevalence of blood born virus infection in this high risk group. Anti-HCV antibodies were found in 75% of sera. Seroprevalence for HIV was found 13%, for hepatitis B markers 68% and none for HTLV-I. Multiple infections have been very frequent.
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [31] Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
    Alavian, Seyed Moayed
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
  • [32] Prevention of hepatitis C virus infection in drug users
    Schulte, B.
    Stoever, H.
    Leicht, A.
    Schnackenberg, K.
    Reimer, J.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2008, 51 (10) : 1210 - 1217
  • [33] The comparison of chronic hepatitis C treatment outcome between intravenous drug users and non-intravenous drug users
    Bojovic, K.
    Simonovic, J.
    Katanic, N.
    Milosevic, I.
    Pesic, I.
    Delic, D.
    Svirtlih, N.
    Jevtovic, D. J.
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (06) : 517 - 520
  • [34] Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh
    Shirin, T
    Ahmed, T
    Iqbal, A
    Islam, M
    Islam, MN
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2000, 18 (03) : 145 - 150
  • [35] High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, China
    Wu, Nana
    Ge, Qinjuan
    Feng, Qingchuan
    Zhang, Jun
    Liu, Xiaoxia
    Sun, Caihong
    Xu, Yongkang
    He, Guangli
    Zhang, Chiyu
    INDIAN JOURNAL OF VIROLOGY, 2011, 22 (02): : 77 - 83
  • [36] Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy
    Hallinan, R
    Byrne, A
    Amin, J
    Dore, GJ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (07) : 1082 - 1086
  • [37] Hepatitis C Virus Genotype Diversity among Intravenous Drug Users in Yunnan Province, Southwestern China
    Zhang, Zhihui
    Yao, Yufeng
    Wu, Wenlong
    Feng, Ruilin
    Wu, Zhongxiang
    Cun, Wei
    Dong, Shaozhong
    PLOS ONE, 2013, 8 (12):
  • [38] Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria
    Tun, W.
    Vu, L.
    Adebajo, S. B.
    Abiodun, L.
    Sheehy, M.
    Karlyn, A.
    Njab, J.
    Ahonsi, B.
    Issa, B. K.
    Idogho, O.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2013, 24 (08) : 619 - 625
  • [39] Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil
    Lopes, Carmen L. R.
    Teles, Sheila A.
    Espirito-Santo, Marcia P.
    Lampe, Elisabete
    Rodrigues, Fabiana P.
    Motta-Castro, Ana Rita C.
    Marinho, Thais A.
    Reis, Nadia R.
    Silva, Agabo M. C.
    Martins, Regina M. B.
    REVISTA DE SAUDE PUBLICA, 2009, 43
  • [40] Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia
    Huntington, Susie
    Folch, Cinta
    Gonzalez, Victoria
    Merono, Merce
    Ncube, Fortune
    Casabona, Jordi
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (04): : 236 - 238
12345